Cargando…

Membrane-wrapped nanoparticles for photothermal cancer therapy

Cancer is a global health problem that needs effective treatment strategies. Conventional treatments for solid-tumor cancers are unsatisfactory because they cause unintended harm to healthy tissues and are susceptible to cancer cell resistance. Nanoparticle-mediated photothermal therapy is a minimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Aboeleneen, Sara B., Scully, Mackenzie A., Harris, Jenna C., Sterin, Eric H., Day, Emily S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373884/
https://www.ncbi.nlm.nih.gov/pubmed/35960404
http://dx.doi.org/10.1186/s40580-022-00328-4
_version_ 1784767680164659200
author Aboeleneen, Sara B.
Scully, Mackenzie A.
Harris, Jenna C.
Sterin, Eric H.
Day, Emily S.
author_facet Aboeleneen, Sara B.
Scully, Mackenzie A.
Harris, Jenna C.
Sterin, Eric H.
Day, Emily S.
author_sort Aboeleneen, Sara B.
collection PubMed
description Cancer is a global health problem that needs effective treatment strategies. Conventional treatments for solid-tumor cancers are unsatisfactory because they cause unintended harm to healthy tissues and are susceptible to cancer cell resistance. Nanoparticle-mediated photothermal therapy is a minimally invasive treatment for solid-tumor cancers that has immense promise as a standalone therapy or adjuvant to other treatments like chemotherapy, immunotherapy, or radiotherapy. To maximize the success of photothermal therapy, light-responsive nanoparticles can be camouflaged with cell membranes to endow them with unique biointerfacing capabilities that reduce opsonization, prolong systemic circulation, and improve tumor delivery through enhanced passive accumulation or homotypic targeting. This ensures a sufficient dose of photoresponsive nanoparticles arrives at tumor sites to enable their complete thermal ablation. This review summarizes the state-of-the-art in cell membrane camouflaged nanoparticles for photothermal cancer therapy and provides insights to the path forward for clinical translation.
format Online
Article
Text
id pubmed-9373884
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-93738842022-08-12 Membrane-wrapped nanoparticles for photothermal cancer therapy Aboeleneen, Sara B. Scully, Mackenzie A. Harris, Jenna C. Sterin, Eric H. Day, Emily S. Nano Converg Review Cancer is a global health problem that needs effective treatment strategies. Conventional treatments for solid-tumor cancers are unsatisfactory because they cause unintended harm to healthy tissues and are susceptible to cancer cell resistance. Nanoparticle-mediated photothermal therapy is a minimally invasive treatment for solid-tumor cancers that has immense promise as a standalone therapy or adjuvant to other treatments like chemotherapy, immunotherapy, or radiotherapy. To maximize the success of photothermal therapy, light-responsive nanoparticles can be camouflaged with cell membranes to endow them with unique biointerfacing capabilities that reduce opsonization, prolong systemic circulation, and improve tumor delivery through enhanced passive accumulation or homotypic targeting. This ensures a sufficient dose of photoresponsive nanoparticles arrives at tumor sites to enable their complete thermal ablation. This review summarizes the state-of-the-art in cell membrane camouflaged nanoparticles for photothermal cancer therapy and provides insights to the path forward for clinical translation. Springer Nature Singapore 2022-08-12 /pmc/articles/PMC9373884/ /pubmed/35960404 http://dx.doi.org/10.1186/s40580-022-00328-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Aboeleneen, Sara B.
Scully, Mackenzie A.
Harris, Jenna C.
Sterin, Eric H.
Day, Emily S.
Membrane-wrapped nanoparticles for photothermal cancer therapy
title Membrane-wrapped nanoparticles for photothermal cancer therapy
title_full Membrane-wrapped nanoparticles for photothermal cancer therapy
title_fullStr Membrane-wrapped nanoparticles for photothermal cancer therapy
title_full_unstemmed Membrane-wrapped nanoparticles for photothermal cancer therapy
title_short Membrane-wrapped nanoparticles for photothermal cancer therapy
title_sort membrane-wrapped nanoparticles for photothermal cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373884/
https://www.ncbi.nlm.nih.gov/pubmed/35960404
http://dx.doi.org/10.1186/s40580-022-00328-4
work_keys_str_mv AT aboeleneensarab membranewrappednanoparticlesforphotothermalcancertherapy
AT scullymackenziea membranewrappednanoparticlesforphotothermalcancertherapy
AT harrisjennac membranewrappednanoparticlesforphotothermalcancertherapy
AT sterinerich membranewrappednanoparticlesforphotothermalcancertherapy
AT dayemilys membranewrappednanoparticlesforphotothermalcancertherapy